JABIL Tijuana, Mexico, Earns MedAccred Accreditation

Detailed audits and inspections confirmed Jabil Tijuana, Mexico, met MedAccred members' requirements for critical manufacturing processes.

MDDI Staff

April 13, 2022

2 Min Read
Staff from the JABIL Tijuana, Mexico, facility celebrate becoming MedAccred accredited for plastics injection molding.Image courtesy of JABIL Tijuana, Mexico

Jabil Tijuana, Mexico, has attained the MedAccred Accreditation for Plastics Injection Molding, becoming the first company in Mexico to do so. Accreditation for this critical manufacturing process was achieved after Jabil met the audit requirements as set by MedAccred subscribing members, MedAccred shared recently in a press release.

“Eight years ago, Jabil integrated our sites in Tijuana to offer over 358,000 square feet of manufacturing space," explained Carlos Padilla, JABIL quality director for Latin America, in the release. "Earning the first MedAccred accreditation in Mexico for this massive, state-of-the-art site opens new opportunities for healthcare companies to improve product development and production with a high-quality, global leader. This accreditation—involving meticulous audits and inspections—confirms the high quality of Jabil’s proprietary processes and supply chain management. It’s really another way to corroborate what our clients have come to expect from Jabil—a trusted partner that provides outstanding, reliable manufacturing services that will support the success of your medical product.”

Mike Mahaz, Jabil's vice president of global business units for medical devices & consumer health, explained that "at Jabil, we successfully balance innovation and technical advances with real-world challenges. This MedAccred Accreditation is a tribute to our team in Tijuana for extending Jabil’s global leadership in supply chain management, quality processes and risk mitigation. It’s an honor to be the first accreditation in Mexico and to receive external validation of the quality of our comprehensive manufacturing services.”

MedAccred's supply chain oversight program for key critical manufacturing processes is managed by medical device companies such as Bausch Health, Baxter, BD, Boston Scientific, Edwards Lifesciences, Johnson & Johnson, Medtronic, Philips, Roche Diagnostics, and Stryker. In a 2019 MD&M Minneapolis panel discussion, Ann Sheldon, vice president, global supplier quality, Medtronic, explained that the program “is really about looking at special processes [in which] we can’t detect defects either through receiving inspection or even in manufacturing inline inspection. A lot of times we will see latent failures that are process related and undetectable. So this will go in and look much deeper at a process than we would through any sort of a QMS audit and be able to show the repeatability of the process and the materials we’ll be getting."

In the most recent press statement, Connie Conboy, director, MedAccred, explained that “MedAccred Accreditation is globally recognized as a hallmark of quality and is a major accomplishment. The medical device industry has incorporated MedAccred into its approach for handling risk, as it demonstrates compliance to industry standards, customer requirements and best practices. I commend JABIL Tijuana, Mexico for achieving MedAccred Accreditation for Plastics Injection Molding, and for their hard work which has finally paid off.”

MedAccred is administered by the Performance Review Institute (PRI), a not-for-profit trade association started in 1990. 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like